Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00659646 · ClinicalTrials.gov registry record · Phase 2
The Safety and Efficacy of an Antibiotic Sponge in Diabetic Patients With Moderately Infected Foot Ulcers
A Phase 2 study, sponsored by Innocoll.
- Completed
- Registry status
- Phase 2
- Development phase
- 56
- Enrollment target
NCT00659646 is a Phase 2 study that has completed, run by Innocoll. The registered enrollment target is 56 participants.
The verdict
NCT00659646, a Phase 2 study, has completed, sponsored by Innocoll.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 56 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the gentamicin-collagen sponge when combined with standard daily wound care and an oral antibiotic (levofloxacin) is safe and effective in treating moderately infected skin ulcers compared to treatment only with standard daily wound care and an oral antibiotic (levofloxacin).
Interventions
- DRUG gentamicin-collagen sponge and levofloxacin
- DRUG Levofloxacin only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2008-04 |
| Est. Completion | 2010-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00659646
The ClinicalTrials.gov registry entry for NCT00659646 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Innocoll, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which gentamicin-collagen sponge and levofloxacin is the first listed.
NCT00659646 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00659646 about?
NCT00659646 is a clinical study titled "The Safety and Efficacy of an Antibiotic Sponge in Diabetic Patients With Moderately Infected Foot Ulcers". The purpose of this study is to determine whether the gentamicin-collagen sponge when combined with standard daily wound care and an oral antibiotic (levofloxacin) is safe and effective in treating moderately infected skin ulcers compared to treatment only with standard daily wound care and an oral ...
What is the current status of trial NCT00659646?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 56 participants. The study started on 2008-04. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00659646?
The interventions under investigation include: gentamicin-collagen sponge and levofloxacin (DRUG), Levofloxacin only (DRUG).
Who is sponsoring clinical trial NCT00659646?
This trial is sponsored by Innocoll, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.